Tag Archives: short

NEJM Day: Boosting RDV, Attacking HCQ

2020-10-18 update: even the SOLIDARITY trial, conducted by pro-Gilead WHO, found Remdesivir ineffective for COVID-19.

On October 8, the New England Journal of Medicine fired a new salvo against Hydroxychloroquine. It published the results of a tragicomic RECOVERY trial, and the “final report” of NIAID study of Gilead’s Remdesivir (Remdeathsivir). 

The fake news media treats this RECOVERY paper as news, and claims it proves that HCQ does not help severe patients. In fact these results were published in the media on June 4. The RECOVERY researchers severely overdosed and poisoned their patients with HCQ. Even with such overdoses of HCQ, no adverse cardiac events occurred, which is consistent with other clinical data. Continue reading NEJM Day: Boosting RDV, Attacking HCQ

Fauci Lied about Cross-Reactivity Study

Dr. Anthony Fauci brazenly lied to Senator Rand Paul, MD, when questioned about preexisting immunity to COVID-19, that some people have from coronavirus common colds. Existence of such cross-reactivity was not in doubt and was acknowledged by Dr. Fauci earlier. But on Wednesday, September 23, Dr. Fauci said “there was a study that recently came out that preexisting immunity to coronaviruses that are common cold do not cross-react with the covid-19”. Continue reading Fauci Lied about Cross-Reactivity Study

NIH Scientists Receive Royalties from Big Pharma

Under 15 U.S. Code § 3710c, federal researchers, whose work was patented and commercialized, receive royalties at the rate of at least 15% of what the US government receives from the licensees, capped at $150,000 per person, per year. NIH and CDC pay their scientists 25% (on amounts over $50,000). These royalties are paid even after the person leaves the government employment and continue after his or her death.

NIH, NIAID, or CDC researcher who contributed to the development of a novel drug or therapy, and was named as one of the inventors on a commercialized patent, may be entitled to $3 million in royalties over the 20-year lifespan of the patent.  Continue reading NIH Scientists Receive Royalties from Big Pharma

HCQ is Effective and Approved

Hydroxychloroquine (HCQ) is approved by the FDA as an antimalarial and anti-rheumatic medication and can be prescribed by doctors for any disease. Neither the issuance nor the revocation of the Emergency Use Authorization (EUA) for HCQ has any impact on its status as an approved drug available for prescriptions. The EUA was only needed to use HCQ from the Strategic National Stockpile. Continue reading HCQ is Effective and Approved

A Study of Actual HCQ Usage is Published in WUWT

Hydroxychloroquine in COVID-19 Treatment, Actual Usage in the USA is published in WUWT. The Supplementary Materials:

Summary.xlsx

Hydroxychloroquine-Actual-Use-USA-Attachment.zip

Based on its results, roughly about 500 thousands Americans were prescribed Hydroxychloroquine for COVID-19 treatment from January through the end of July.

If Hydroxychloroquine were 1/100th as dangerous as fake scientists claim, the media would be choke full of stories about naive citizens, that died from the “Trump touted drug”. Instead, the media regurgitates the story from March 23, when a man died from ingesting fish tank cleaner with chloroquine phosphate. The police suspected that was a murder, but decided to call it an incident.

Same day correction: the rough estimate is changed to ~500,000.

2020-08-25: The Supplementary Materials are uploaded

IDSA against HCQ and Plasma

Two days ago, the Infectious Disease Society (IDSA) published its recommendations against the use of Hydroxychloroquine and convalescent plasma for the treatment of COVID-19. Apparently, they knew that Trump would announce the FDA authorization of plasma therapy for COVID-19, and they wanted to strike  preemptively. At the same time, they recommended the use of the ineffective and unsafe drug, Remdesivir. Continue reading IDSA against HCQ and Plasma

Convalescent Plasma is OK, but HCQ is Better

Convalescent plasma has been widely and successfully used as a COVID-19 treatment. For example, a survey Sermo W3, April 15, shows that 46% of the doctors that had used convalescent plasma or had seen it used, said it is very or extremely effective against COVID-19.

Plasma has been positively mentioned in Hydroxychloroquine-based COVID-19 Treatment, A Systematic Review of Clinical Evidence and Expert Opinion from Physicians’ Surveys.

Continue reading Convalescent Plasma is OK, but HCQ is Better

Oseltamivir and QT Interval

The Brazilian trial, Borba et al. [3], in which critically ill patients were given toxic doses of chloroquine (not hydroxychloroquine), also included oseltamivir. Oseltamivir (Tamiflu®) is known to prolong QT interval [1]. It is also known to cause Bradycardia, both confirmed by animal experiments [2] (citing [1] for the results in humans). The NIH COVID-19 Treatment Guidelines described the Brazilian HCQ trial in detail, but failed to mention that oseltamivir is known to prolong QT interval on its own. The NIH Guidelines also failed to mention that the study authors stressed that the findings cannot be extrapolated to non-severe cases (emphasis is mine): Continue reading Oseltamivir and QT Interval

Multiple Causes of Increase in C19 Cases & Hospitalizations

Update 2020-08-12. A push for more testing might have caused increase in the COVID-19 infection cases, hospitalizations, and deaths. Some doctors require patients with COVID-19 symptoms to have a PCR test before prescribing HCQ-based treatment. More testing caused longer processing times. Consequently, many COVID-19 patients could not receive Hydroxychloroquine-based treatment in time. Some of them ended up in hospitals or even worse. Even patients, who got over it without visible consequences, carried a higher viral load for longer time and spread it wider, compared with those who received HCQ treatment immediately  or after a short wait. Thus, excessive testing was harmful.

The testing numbers were increasing all the time. In the end of June, a push to suddenly increase the demand for PCR tests started, possibly under influence of somebody attempting to overwhelm the existing testing capacities. Continue reading Multiple Causes of Increase in C19 Cases & Hospitalizations

Google Blacklisting vs Copyright

To create its search index, Google crawls websites. On each website, Google Crawler copies the entire content of the website and processes it.  It stores the full content into its database, extracts links to other websites, aiding its efforts to rank them, uses it to train its artificial intelligence, etc.

But the most websites’ content is protected by copyright. What gives Google the right to copy this content and to benefit from it without permission or compensation? Google CEO Eric Schmidt’s response – “This is how Google works” – is not good enough. This is not fair use. A trillion-dollar company cannot simply take the labor of millions of individuals or small companies and claim fair use. Continue reading Google Blacklisting vs Copyright

HCQ, Gilead and MOTU

The aggressive promotion of Remdesivir by Gilead Sciences (GILD) contributed to the campaign against HCQ, the key part of the most effective treatment for C19. Google, Facebook, Twitter, Microsoft, and the fake news media led attacks against HCQ. Gilead Sciences is headquartered in the Silicon Valley.

The following table shows a surprising concentration of publicly traded shares of Gilead, Big Tech / (anti-) social media, and the New York Times in the hands of a small group of 6-8 investment management corporations. Continue reading HCQ, Gilead and MOTU

CrowdStrike behind Guccifer 2.0

Guccifer 2.0 (G2) was not a persona created by Russian intelligence because Russian intel had nothing to do with the exfiltration and the publication of the internal documents of the DNC, DCCC, and John Podesta. Furthermore, Dmitri Alperovitch, co-founder and the chief technological officer of CrowdStrike, was probably (but not certainly) behind G2. CrowdStrike was a cybersecurity contractor hired by the DNC/DCCC law firm Perkins-Coie to assist it and/or its client DNC on cybersecurity matters in late April 2016. The fact that Perkins-Coie hired CrowdStrike to aid it in the contentious representation of the DNC was not known until very recently. The untruthful but publicly disseminated version of the events was that the DNC hired CrowdStrike in early May 2016 to remediate the DNC network breach. The CrowdStrike misattributed the breach to Russian intelligence and provided alleged “forensic evidence” to the FBI. G2 was not a Romanian hacker, and not a hacker at all.

Dmitri Alperovitch can be identified as the single individual behind the G2 persona by the classic combination of means, motives, and opportunities. Additionally, G2’s linguistic and cultural traits are a match to Alperovitch. G2 persona shows affinity with CrowdStrike.

CrowdStrike Inc. wholly owned CrowdStrike Services, Inc. Shawn Henry, an executive assistant to the FBI Director Robert Mueller, has been President of CrowdStrike Services since he resigned from the FBI.

CrowdStrike-Guccifer-2.pdf

JAMA Rejected my Comment on Masks and HCQ

JAMA Current  has rejected my comment to a recent peer-reviewed paper, used by the CDC to justify recommendations of universal masking and to downplay the role of hydroxychloroquine in preventing COVID-19 spread. It is well known that health care workers have been taking hydroxychloroquine for COVID-19 prevention, and rightfully so. Such use increased after President Trump mentioned chloroquine derivatives in a March 19 briefing. For example, NPR wrote on March 23: Continue reading JAMA Rejected my Comment on Masks and HCQ